You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 7,011,815


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,011,815
Title:Diagnostic imaging contrast agents with extended blood retention
Abstract:The present invention relates to contrast agents for diagnostic imaging with prolonged blood retention. In particular, this invention relates to novel compounds that are characterized by an image enhancing moiety (IEM); a protein plasma binding moiety (PPBM); and a blood half-life extending moiety (BHEM). This invention also relates to pharmaceutical compositions comprising these compounds and to methods of using the compounds and compositions for blood half-life extension and contrast enhancement of diagnostic imaging.
Inventor(s): McMurry; Thomas J. (Winchester, MA), Sijiki; Hironao (Gifu, JP), Scott; Daniel M. (Acton, MA), Lauffer; Randall B. (Brookline, MA)
Assignee: Epix Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:10/354,723
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,011,815: A Deep Dive

Introduction

When examining a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the specifics of United States Patent 7,011,815, focusing on its claims, scope, and the broader patent landscape.

Overview of the Patent

United States Patent 7,011,815, titled "Diagnostic imaging contrast agents with extended blood retention," pertains to the development of contrast agents used in diagnostic imaging. These agents are designed to enhance the visibility of internal body structures during medical imaging procedures.

Claims Analysis

Independent Claims

The independent claims of a patent define the broadest scope of the invention. For US Patent 7,011,815, these claims typically include the composition of the contrast agents, their method of preparation, and their use in diagnostic imaging.

  • Claim 1: This claim usually outlines the core composition of the contrast agent, including the specific molecules or compounds involved and their structural characteristics.
  • Claim 2: This might detail the method of synthesizing the contrast agent, including any specific steps or conditions required.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations or features.

  • Claim 3: This could specify particular applications of the contrast agent, such as its use in MRI or CT scans.
  • Claim 4: This might describe specific dosages or administration methods for the contrast agent.

Scope of the Patent

The scope of a patent is defined by its claims and is critical in determining what is protected and what is not.

Claim Language and Scope

The language used in the claims is pivotal. Broad claims can encompass a wide range of variations, while narrow claims are more specific and limited. For US Patent 7,011,815, the scope would include any diagnostic imaging contrast agents that fall within the described composition and method of preparation.

Patent Scope Metrics

Research has shown that patent scope can be measured using metrics such as independent claim length and independent claim count. Patents with narrower claims at publication tend to have a higher probability of grant and a shorter examination process[3].

Patent Landscape

Related Patents and Technologies

The patent landscape for diagnostic imaging contrast agents is complex, with numerous patents covering various aspects of contrast agent design, synthesis, and application.

  • Competing Patents: Other patents in this field might cover different types of contrast agents or alternative methods of synthesis. For example, patents like WO-2008022263-A3 focus on methods for lymph system imaging, which, while distinct, operate within the broader domain of diagnostic imaging[5].

Industry Trends and Innovations

The field of diagnostic imaging is continuously evolving, with advancements in technology and materials science leading to new and improved contrast agents.

  • Recent Innovations: Patents filed in recent years, such as those by Volkswagen and Toyota, highlight the integration of advanced technologies like sensor data and inter-vehicle communication, although these are more related to automotive than medical imaging[1].

Legal Considerations

Claim Construction and Validity

The construction of patent claims is a critical legal issue. Claims must be clear and definite to be valid. The Federal Circuit has emphasized that claims must "inform those skilled in the art about the scope of the invention with reasonable certainty"[2].

  • Indefiniteness: If the claims are too broad or ambiguous, they can be deemed indefinite, leading to invalidation. This was seen in cases like Horizon Pharma, Inc. v. Dr. Reddy's Laboratories, Inc., where the term "target" was found to be indefinite[2].

Market Impact

Licensing and Litigation

The scope and claims of a patent can significantly impact its market value and the potential for licensing and litigation.

  • Licensing: Clear and valid claims can make a patent more attractive for licensing, as they provide a well-defined scope of protection.
  • Litigation: Broad or ambiguous claims can lead to costly litigation, as seen in debates over patent quality and the criticism of overly broad software and internet patents[3].

Key Takeaways

  • Clear Claims: The clarity and definiteness of patent claims are crucial for their validity and enforceability.
  • Scope Metrics: Metrics like independent claim length and count can help in assessing the scope and potential success of a patent.
  • Industry Context: Understanding the broader patent landscape and industry trends is essential for navigating the complexities of patent law.
  • Legal Considerations: The construction and validity of claims are critical legal issues that can impact the patent's market value and potential for licensing and litigation.

FAQs

  1. What is the main focus of United States Patent 7,011,815?

    • The main focus is on diagnostic imaging contrast agents with extended blood retention.
  2. How are the claims of a patent typically structured?

    • The claims are structured into independent claims that define the broadest scope of the invention and dependent claims that narrow down the scope by adding additional limitations.
  3. Why is claim clarity important in patent law?

    • Claim clarity is important because it ensures that the scope of the invention is well-defined and understood by those skilled in the art, which is a requirement for patent validity.
  4. What metrics can be used to measure patent scope?

    • Metrics such as independent claim length and independent claim count can be used to measure patent scope and predict the likelihood of patent grant and examination duration[3].
  5. How does the patent landscape affect the value of a patent?

    • The patent landscape, including competing patents and industry trends, can significantly affect the value of a patent by influencing its market relevance, licensing potential, and litigation risks.

Sources

  1. Justia Patents: Traffic Analysis Or Control Of Surface Vehicle Patents and Patent Applications.
  2. CAFC: Horizon Pharma, Inc. v. Dr. Reddy's Laboratories, Inc.
  3. Hoover Institution: Patent Claims and Patent Scope.
  4. Altmetric: Biliary Excretion of Chelated Iron.
  5. PubChem: Methods for lymph system imaging - Patent WO-2008022263-A3.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,011,815

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,011,815

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0806968 ⤷  Subscribe 300253 Netherlands ⤷  Subscribe
European Patent Office 0806968 ⤷  Subscribe PA2007003 Lithuania ⤷  Subscribe
European Patent Office 0806968 ⤷  Subscribe CA 2007 00016 Denmark ⤷  Subscribe
European Patent Office 0806968 ⤷  Subscribe SPC 037/2006 Ireland ⤷  Subscribe
European Patent Office 0806968 ⤷  Subscribe SPC/GB07/011 United Kingdom ⤷  Subscribe
European Patent Office 0806968 ⤷  Subscribe PA2007003,C0806968 Lithuania ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.